Interní Med. 2012; 14(3): 119-121

Vulvovaginal discomfort of fungal origin: current status and therapeutic options

doc.MUDr.Jiří Špaček, Ph.D.1, doc.RNDr.Vladimír Buchta, CSc.2, MUDr.Jan Kestřánek1
1 Porodnická a gynekologická klinika, LF a FN v Hradci Králové
2 Ústav klinické mikrobiologie, LF a FN v Hradci Králové

Vulvovaginal candidiasis is the most common vaginal disease and it is also the most frequent cause of vulvovaginal discomfort (itching,

burning and discharge). It affects most women at some point in their lives and its sporadic form is usually managed without difficulty. By

contrast, in recurrent conditions symptoms escalate and the gynaecological finding is often very poor or completely normal. Sometimes

it is possible to determine the inciting moment; however, the actual cause mostly remains undiscovered. Moreover, in a number of cases,

the finding of yeast may not necessarily confirm fungal aetiology and the term recurrent vulvovaginal candidiasis fails to reflect the nature

of the condition. While in acute sporadic cases one-time anti-infective treatment is highly effective, in chronic vulvovaginal discomfort

it tends to have a transient effect only. In the long-term perspective, it is advisable to rather improve the quality of the vaginal milieu in

these patients. The vagina and vulva are strongly oestrogen-dependent; therefore, hormonal intervention may also be an option.

Keywords: vulvovaginal discomfort, disturbance in the vaginal milieu, vulvovaginal candidiasis

Published: March 26, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Špaček J, Buchta V, Kestřánek J. Vulvovaginal discomfort of fungal origin: current status and therapeutic options. Interní Med. 2012;14(3):119-121.
Download citation

References

  1. Berg AO, Heidrich FE, Fihn SD, et al. Establishing the cause of genitourinary symptoms in women in a family practice. JAMA 1984; 251: 620-625. Go to original source...
  2. Kent HL. Epidemiology of vaginitis. Am. J. Obstet. Gynecol. 1991; 165: 1168-1176. Go to original source... Go to PubMed...
  3. Špaček J, Buchta V. Itraconazole in the treatment of acute and recurrent vaginal candidosis: Comparison of the therapeutic effectiveness and occurrence of relapses in one-day and three-day regimens. Mycoses 2005a; 48: 165-171. Go to original source... Go to PubMed...
  4. Špaček J, Buchta V, Veselský Z, et al. Interakce kvasinek s hostitelem ve vztahu k urogenitálnímu traktu, vulvovaginální kandidóza, urologické aspekty mykotických onemocnění. Čs. Gynekol. 2003; 68: 432-439.
  5. Špaček J, Buchta V, Jílek P, et al. Clinical aspects and luteal phase assessment in patients with recurrent vulvovaginal candidiasis. Eur. J. Obst. Gyn. Repr. Biol. 2007; 131: 198-202. Go to original source... Go to PubMed...
  6. Špaček J, Buchta V, Jílek P, et al. What does it mean the diagnosis of recurrent vulvovaginal candidiasis? 9th Congress for Infectious and Immunological Diseases in Obstetrics and Gynaecology, Urology and Dermatology, November 19-26, 2005b, Maceio, Brazil, Book of Abstracts (62).
  7. Buchta V, Špaček J, Jílek P. Mykotické infekce ženského genitálu III. Terapie. Gynekolog 1998; 7: 73-82.
  8. Buchta V, Slezák R, Špaček J, et al. Současné možnosti léčby kožních a slizničních mykóz. Med Pro Praxi 2009; 6: 155-164.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.